Rekvina Laboratories Ltd.BSE: VINRKLB

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

· Issued by Rekvina Laboratories Ltd. via BSE India

On 6ix: 6ix.com/news/disclosures-under-reg-291-of-sebi-sast-regulations-2011-168

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilsan Pharma Impex Pvt Ltd

View Attachment

View original source (BSE India)Rekvina Laboratories Ltd. on 6ix

Earlier from Rekvina Laboratories

Later from Rekvina Laboratories

All Rekvina Laboratories news releases